Constituents of <em>Coreopsis lanceolata</em> Flower and Their Dipeptidyl Peptidase IV Inhibitory Effects

Constituents of <em>Coreopsis lanceolata</em> Flower and Their Dipeptidyl Peptidase IV Inhibitory Effects

A new polyacetylene glycoside, (5<i>R</i>)-6<i>E</i>-tetradecene-8,10,12-triyne-1-ol-5-<i>O</i>-<i>β</i>-glucoside (<b>1</b>), was isolated from the flower of <i>Coreopsis lanceolata</i> (Compositae), together with two known com...

Full description

Bibliographic Details
Main Authors:	Bo-Ram Kim, Sunil Babu Paudel, Joo-Won Nam, Chang Hyun Jin, Ik-Soo Lee, Ah-Reum Han
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Molecules
Subjects:	<i>Coreopsis lanceolata</i> polyacetylene glycoside flavonoid dipeptidyl peptidase IV type 2 diabetes mellitus.
Online Access:	https://www.mdpi.com/1420-3049/25/19/4370

Similar Items

Metabolite Profiling and Dipeptidyl Peptidase IV Inhibitory Activity of <i>Coreopsis</i> Cultivars in Different Mutations
by: Bo-Ram Kim, et al.
Published: (2021-08-01)

The multiple actions of dipeptidyl peptidase 4 (DPP-4) and its pharmacological inhibition on bone metabolism: a review
by: L. M. Pechmann, et al.
Published: (2024-07-01)

Identification and Characterization of Dipeptidyl Peptidase-IV Inhibitory Peptides from Oat Proteins
by: Wei Wang, et al.
Published: (2022-05-01)

Identification and dipeptidyl peptidase IV (DPP-IV) inhibitory activity verification of peptides from mouse lymphocytes
by: Juan Wang, et al.
Published: (2022-11-01)

Inhibitory effects of selected cannabinoids against dipeptidyl peptidase IV, an enzyme linked to type 2 diabetes
by: Lithalethu Mkabayi, et al.
Published: (2024-01-01)

Molecular Characterization and Functional Analysis of the Dipeptidyl Peptidase IV from Venom of the Ectoparasitoid <i>Scleroderma guani</i>
by: Chaoyan Wu, et al.
Published: (2023-04-01)

Coreolanceolins A–E, New Flavanones from the Flowers of <i>Coreopsis lanceolate,</i> and Their Antioxidant and Anti-Inflammatory Effects
by: Hyoung-Geun Kim, et al.
Published: (2020-06-01)

A comprehensive review of Coreopsis lanceolata: assessing its invasion risk and ecological impact
by: Eunhee Cho, et al.
Published: (2024-08-01)

Coreopsis spp.Tickseed, Coreopsis
by: Edward Gilman
Published: (2007-06-01)

Aurones and Flavonols from <i>Coreopsis lanceolata</i> L. Flowers and Their Anti-Oxidant, Pro-Inflammatory Inhibition Effects, and Recovery Effects on Alloxan-Induced Pancreatic Islets in Zebrafish
by: Hyoung-Geun Kim, et al.
Published: (2021-10-01)

Preparation and Purification of Dipeptidyl Peptidase-IV Inhibitory Peptides from Pearl Mussel Muscle
by: ZHANG Chuhan, CHEN Yinge, MA Ting, WENG Ling, ZHANG Lingjing, ZHANG Genfang, CAO Minjie
Published: (2024-09-01)

Efficacy and Safety of the Utilization of Dipeptidyl Peptidase IV Inhibitors in Diabetic Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials
by: Mahzari MM, et al.
Published: (2024-03-01)

Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes
by: Anand-Krishna Singh, et al.
Published: (2021-06-01)

Dipeptidyl Peptidase-IV Inhibitory Activity and Related Molecular Mechanism of Bovine α-Lactalbumin-Derived Peptides
by: Jing Gao, et al.
Published: (2020-06-01)

Progress on application of dipeptidyl peptidase Ⅲ in the treatment of sepsis
by: WANG Yingchen, SUN Liqun
Published: (2023-01-01)

Comprehensive Chemical Analysis of <i>Codonopsis lanceolata</i> Roots Using Ultra-High-Performance Liquid Chromatography–Quadrupole-Exactive–Orbitrap Mass Spectrometry
by: Chang Luo, et al.
Published: (2025-01-01)

A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes
by: Sibhghatulla Shaikh, et al.
Published: (2021-06-01)

Neurological Sequelae of Post-COVID-19 Fatigue: A Narrative Review of Dipeptidyl Peptidase IV-Mediated Cerebrovascular Complications
by: Che Mohd Nasril Che Mohd Nassir, et al.
Published: (2024-11-01)

Mechanistic Study of Novel Dipeptidyl Peptidase IV Inhibitory Peptides from Goat’s Milk Based on Peptidomics and In Silico Analysis
by: Yulong Wu, et al.
Published: (2024-04-01)

Neuroprotective Effects of <i>Coreopsis lanceolata</i> Flower Extract against Oxidative Stress-Induced Apoptosis in Neuronal Cells and Mice
by: Hyung Don Kim, et al.
Published: (2021-06-01)

Identification of potential dipeptidyl peptidase IV inhibitors from the ConMedNP library by virtual screening, and molecular dynamics methods
by: Hans Merlin Tsahnang Fofack, et al.
Published: (2024-08-01)

Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease
by: James D. Chalmers, et al.
Published: (2023-12-01)

Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study
by: Dejan Agić, et al.
Published: (2021-06-01)

Composition and Antioxidant Activities of Volatile Organic Compounds in Radiation-Bred <i>Coreopsis</i> Cultivars
by: Bo-Ram Kim, et al.
Published: (2020-06-01)

Curcumin inhibits growth of Porphyromonas gingivalis by arrest of bacterial dipeptidyl peptidase activity
by: Hiroki Murai, et al.
Published: (2024-12-01)

Analysis of Citrus Bioflavonoid Content and Dipeptidyl Peptidase-4 Inhibitory Potential of Commercially Available Supplements
by: Ankit Gupta, et al.
Published: (2022-07-01)

Survey of Dipeptidyl Peptidase III Inhibitors: From Small Molecules of Microbial or Synthetic Origin to Aprotinin
by: Marija Abramić, et al.
Published: (2022-05-01)

Molecular Dynamics Simulations Study of the Interactions between Human Dipeptidyl-Peptidase III and Two Substrates
by: Shitao Zhang, et al.
Published: (2021-10-01)

Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis
by: Ilaria Barchetta, et al.
Published: (2022-09-01)

Simultaneous Natural Deep Eutectic Solvent-Based Ultrasonic-Assisted Extraction of Bioactive Compounds of Cinnamon Bark and Sappan Wood as a Dipeptidyl Peptidase IV Inhibitor
by: Islamudin Ahmad, et al.
Published: (2020-08-01)

Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease
by: Hun Jee Choe, et al.
Published: (2024-08-01)

The Association Between Circulating Klotho and Dipeptidyl Peptidase-4 Activity and Inflammatory Cytokines in Elderly Patients With Alzheimer Disease
by: Mohsen Sedighi, et al.
Published: (2020-05-01)

Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus
by: Jie Meng, et al.
Published: (2023-12-01)

Cheminformatics Identification and Validation of Dipeptidyl Peptidase-IV Modulators from Shikimate Pathway-Derived Phenolic Acids towards Interventive Type-2 Diabetes Therapy
by: Fatai Oladunni Balogun, et al.
Published: (2022-10-01)

Association of serum and salivary dipeptidyl peptidase-4 (DPP-4) with oral cancerous and precancerous lesions; an observational diagnostic accuracy study
by: Nayroz Abdel Fattah Tarrad, et al.
Published: (2024-10-01)

Ocular cicatricial pemphigoid following Dipeptidyl Peptidase-4 inhibitor use: A case report
by: Akifumi Matsumoto, et al.
Published: (2023-12-01)

Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury
by: Bruno Garcia, et al.
Published: (2024-06-01)

Modulation of dipeptidyl peptidase IV by Rooibos tea metabolites towards type 2 diabetes care: Evidence from molecular dynamics simulation and density functional theory
by: Lukman HY, et al.
Published: (2024-06-01)

Rurality is associated with lower likelihood of dipeptidyl peptidase 4 inhibitor use for treatment intensification
by: Danielle K. Nagy, et al.
Published: (2024-03-01)

Association of Dipeptidiyl Peptidase-4 Inhibitors and Bullose Pemphigoid: A Report of Four Cases
by: Neslihan USLU, et al.
Published: (2024-06-01)